Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
2
×
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
2
×
fda
2
×
indiana blog main
indiana top stories
life sciences
loxo oncology
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
2025
ad-comm
affimed
akcea therapeutics
allogene therapeutics
amicus therapeutics
approval
apremilast
base editing
bio
biogen
biome
What
cancer
2
×
new
2
×
allogene
approved
bio
crispr
deeper
diversity
dna
drug
fda
fingerprint
genetic
going
hot
immunotherapy
investors
ipo
juno
matter
medicine
million
nd
nearly
oks
remains
roundup
second
shares
snapped
targets
therapeutics
ticket
time
tissues
tumor's
utero
world
years
Language
Current search:
new
×
cancer
×
" boston blog main "
×
" detroit top stories "
×
fda
×
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More